查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390995

2024 年辅助生殖技术全球市场报告

Assisted Reproductive Technology Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

到2023年，欧洲将成为辅助生殖技术市场最大的地区。北美是辅助生殖技术市场的第二大地区。辅助生殖技术（ART）报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 辅助生殖科技市场特点

第三章辅助生殖科技市场趋势与策略

第四章辅助生殖技术市场-宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章 全球辅助生殖技术市场规模及成长

  • 全球辅助生殖技术市场的驱动因素与抑制因素
    • 市场驱动力
    • 市场抑制因素
  • 2018-2023年全球辅助生殖技术市场规模实绩与成长
  • 2023-2028、2033年全球辅助生殖技术市场规模及成长预测

第六章辅助生殖技术市场区隔

  • 全球辅助生殖技术市场，按诊断、实绩和预测细分，2018-2023、2023-2028、2033
  • 排卵测试药
  • 造影
  • 卵巢储备测试
  • 基因检测
  • 全球辅助生殖科技市场，依手术类型细分、实绩与预测，2018-2023、2023-2028、2033
  • 活体捐赠者
  • 活体捐赠者
  • 冷冻供体
  • 冷冻非捐赠者
  • 胚胎或卵子的保存
  • 全球辅助生殖科技市场，依最终使用者细分，实绩与预测，2018-2023、2023-2028、2033
  • 医院
  • 不孕不育诊所
  • 其他最终用户

第 7 章：辅助生殖技术市场区域与国家分析

  • 全球辅助生殖技术市场，按地区、实绩及预测，2018-2023、2023-2028、2033
  • 全球辅助生殖技术市场，依国家、实绩及预测，2018-2023、2023-2028、2033

第八章亚太辅助生殖科技市场

第九章 中国辅助生殖技术市场

第十章 印度辅助生殖技术市场

第十一章 日本辅助生殖技术市场

第十二章 澳洲辅助生殖技术市场

第十三章 印尼辅助生殖技术市场

第十四章 韩国辅助生殖技术市场

第十五章西欧辅助生殖技术市场

第十六章英国辅助生殖技术市场

第十七章 德国辅助生殖技术市场

第十八章 法国辅助生殖技术市场

第十九章 义大利辅助生殖技术市场

第二十章 西班牙辅助生殖技术市场

第二十一章 东欧辅助生殖科技市场

第22章 俄罗斯辅助生殖技术市场

第23章 北美辅助生殖技术市场

第24章美国辅助生殖技术市场

第25章加拿大辅助生殖技术市场

第26章南美洲辅助生殖技术市场

第27章 巴西辅助生殖技术市场

第28章 中东辅助生殖技术市场

第29章 非洲辅助生殖科技市场

第三十章 辅助生殖技术市场竞争形势及企业概况

  • 辅助生殖技术市场竞争形势
  • 辅助生殖技术市场的公司概况
    • Cooper Surgical Inc.
    • Ferring Pharmaceuticals Ltd.
    • Hamilton Thorne Ltd.
    • Merck KGaA
    • Genea Limited

第三十一章 全球辅助生殖科技市场竞争基准化分析

第32章全球辅助生殖技术市场竞争仪表板

第三十三章 辅助生殖科技市场重大併购

第34章 辅助生殖技术市场未来前景及潜力分析

第35章附录

简介目录
Product Code: r9355

“Assisted Reproductive Technology Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on assisted reproductive technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for assisted reproductive technology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The assisted reproductive technology market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Diagnosis: Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing
  • 2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo Or Egg Banking
  • 3) By End-User: Hospitals; Fertility Clinics; Other End-Users
  • Companies Mentioned: Cooper Surgical Inc.; Ferring Pharmaceuticals Ltd.; Hamilton Thorne Ltd.; Merck KGaA; Genea Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Assisted reproductive technology (ART) involves surgically removing eggs from women's ovaries, combining them with men's sperm in a laboratory to form embryos, and then reintroducing these embryos into the woman's body. ART procedures may utilize donor eggs, donor sperm, or previously stored frozen embryos, and they are employed in the treatment of infertility related to eggs or embryos.

The primary types of assisted reproductive technology include in-vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo replacement (FER), and other related procedures. In-vitro fertilization (IVF) is a complex process wherein eggs are retrieved, fertilized with sperm in a laboratory to create embryos, and then implanted into the reproductive organs of women. Procedure types within ART encompass fresh non-donor, fresh donor, frozen donor, frozen non-donor, as well as embryo or egg banking. These technologies find application in various healthcare settings, including hospitals, fertility clinics, and other related facilities.

The assisted reproductive technology (ART) market research report is one of a series of new reports from The Business Research Company that provides assisted reproductive technology (ART) market statistics, including assisted reproductive technology (ART) industry global market size, regional shares, competitors with a assisted reproductive technology (ART) market share, detailed assisted reproductive technology (ART) market segments, market trends and opportunities, and any further data you may need to thrive in the assisted reproductive technology (ART) industry. This assisted reproductive technology (ART) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The assisted reproductive technology market size has grown rapidly in recent years. It will grow from $38.04 billion in 2023 to $45.42 billion in 2024 at a compound annual growth rate (CAGR) of 19.4%. The increase in the historic period can be attributed to factors such as the rise in infertility rates, evolving societal norms, increased awareness, legislative support, and an aging population.

The assisted reproductive technology market size is expected to see rapid growth in the next few years. It will grow to $91.8 billion in 2028 at a compound annual growth rate (CAGR) of 19.2%. The anticipated growth in the forecast period can be attributed to factors such as increasing maternal age, a rising demand for same-sex parenting, the prevalence of medical tourism, the expansion of healthcare infrastructure, and ongoing research and development in the field. Key trends expected in this period involve the utilization of artificial intelligence (AI), the adoption of egg freezing, the implementation of single-embryo transfer (SET), as well as the use of preimplantation genetic testing for aneuploidy (PGT-A) and genetic screening. Additionally, innovative fertility preservation techniques are expected to play a significant role in shaping the landscape of assisted reproductive technology.

The assisted reproductive technology market is anticipated to experience growth due to the increasing number of infertility cases. Infertility, diagnosed after a year of unsuccessful attempts to conceive, impacts a significant portion of the global adult population, affecting approximately 1 in 6 adults or 17.5% globally, as stated by the World Health Organization in April 2023. As a result, the rising prevalence of infertility cases is propelling the demand for assisted reproductive technology (ART), which encompasses fertility treatments involving both male and female reproductive components.

The escalating prevalence of obesity is poised to drive the growth of the ART market in the future. Obesity, characterized by excessive body fat accumulation that may affect health, can lead to irregular menstrual cycles, ovulatory dysfunction, and decreased sperm quality, thereby increasing infertility risks. The World Heart Federation reported in March 2023 that around 2.3 billion individuals, including adults and children, were affected by obesity or being overweight globally. Projections indicate that by 2025, this number may soar to 2.7 billion, underscoring the significant impact of obesity on fertility and the subsequent demand for specialized ART services.

A prominent trend shaping the ART market is the advancement of technology. Leading companies are actively developing technological solutions to fortify their positions within the industry. Notably, Alife Health introduced the Alife Assist platform in October 2022, an innovative suite of products leveraging data-driven insights and artificial intelligence (AI) to transform the in-vitro fertilization (IVF) process. This platform, consisting of Stim Assist, Embryo Assist, and Insights, caters to reproductive endocrinologists, embryologists, and clinic administrators, aiding in clinical decision-making, streamlining IVF clinic operations, and optimizing medication dosing, embryo grading, and real-time performance monitoring. The implementation of such technology not only enhances the patient experience but also improves success rates in IVF procedures.

Leading companies in the assisted reproductive technology (ART) sector are spearheading the development of innovative products to gain a competitive edge in the market. For example, in July 2023, Thermo Fisher Scientific Inc., a renowned US-based biotechnology firm, introduced two pioneering next-generation sequencing-based options specifically crafted to support preimplantation genetic testing-aneuploidy (PGT-A) in the context of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research. The cutting-edge products, namely the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, are tailored for use in reproductive health labs. These are the first research-use assays in the field, and they are compatible with the Ion Torrent Genexus Integrated Sequencer, providing a comprehensive workflow from the initial sample to the final result for aneuploidy analysis. PGT-A testing facilitates the identification of chromosomal irregularities in embryo samples, offering researchers invaluable genetic insights to potentially bolster the success rate of future pregnancies and improve the health of future generations. The Genexus Integrated Sequencer streamlines the research process by enabling templating, sequencing, and analysis on a single platform. Additionally, the Ion AmpliSeq Polyploidy Panel kit includes quality control features designed to detect contamination, prevent sample mix-ups, and identify triploidy in embryos.

In August 2021, Virtus Health Limited, an Australia-based company specializing in ART, executed the acquisition of Adora Fertility and three-day hospitals from Healius Limited for an estimated $45.0 million. This strategic acquisition is anticipated to fortify Virtus Health's portfolio, particularly in in-vitro fertilization (IVF). Adora Fertility, an Australia-based enterprise, provides ART services, including IVF and ICSI, catering to assisted reproductive technologies.

Major companies operating in the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

Europe was the largest region in the assisted reproductive technology market in 2023. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology (ART) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the assisted reproductive technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The assisted reproductive technology market includes revenues earned by entities by gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), and frozen embryo transfer (FET). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Assisted Reproductive Technology Market Characteristics

3. Assisted Reproductive Technology Market Trends And Strategies

4. Assisted Reproductive Technology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Assisted Reproductive Technology Market Size and Growth

  • 5.1. Global Assisted Reproductive Technology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Assisted Reproductive Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Assisted Reproductive Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Assisted Reproductive Technology Market Segmentation

  • 6.1. Global Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ovulation Testing
  • Hysterosalpingography
  • Ovarian Reserve Testing
  • Genetic Testing
  • 6.2. Global Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fresh Non-Donor
  • Fresh Donor
  • Frozen Donor
  • Frozen Non-Donor
  • Embryo Or Egg Banking
  • 6.3. Global Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Fertility Clinics
  • Other End-Users

7. Assisted Reproductive Technology Market Regional And Country Analysis

  • 7.1. Global Assisted Reproductive Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Assisted Reproductive Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Assisted Reproductive Technology Market

  • 8.1. Asia-Pacific Assisted Reproductive Technology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Assisted Reproductive Technology Market

  • 9.1. China Assisted Reproductive Technology Market Overview
  • 9.2. China Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Assisted Reproductive Technology Market

  • 10.1. India Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Assisted Reproductive Technology Market

  • 11.1. Japan Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Assisted Reproductive Technology Market

  • 12.1. Australia Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Assisted Reproductive Technology Market

  • 13.1. Indonesia Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Assisted Reproductive Technology Market

  • 14.1. South Korea Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Assisted Reproductive Technology Market

  • 15.1. Western Europe Assisted Reproductive Technology Market Overview
  • 15.2. Western Europe Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Assisted Reproductive Technology Market

  • 16.1. UK Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Assisted Reproductive Technology Market

  • 17.1. Germany Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Assisted Reproductive Technology Market

  • 18.5. France Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Assisted Reproductive Technology Market

  • 19.9. Italy Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Assisted Reproductive Technology Market

  • 20.13. Spain Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Assisted Reproductive Technology Market

  • 21.1. Eastern Europe Assisted Reproductive Technology Market Overview
  • 21.2. Eastern Europe Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Assisted Reproductive Technology Market

  • 22.1. Russia Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Assisted Reproductive Technology Market

  • 23.1. North America Assisted Reproductive Technology Market Overview
  • 23.2. North America Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Assisted Reproductive Technology Market

  • 24.1. USA Assisted Reproductive Technology Market Overview
  • 24.2. USA Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Assisted Reproductive Technology Market

  • 25.1. Canada Assisted Reproductive Technology Market Overview
  • 25.2. Canada Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Assisted Reproductive Technology Market

  • 26.1. South America Assisted Reproductive Technology Market Overview
  • 26.2. South America Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Assisted Reproductive Technology Market

  • 27.1. Brazil Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Assisted Reproductive Technology Market

  • 28.1. Middle East Assisted Reproductive Technology Market Overview
  • 28.2. Middle East Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Assisted Reproductive Technology Market

  • 29.1. Africa Assisted Reproductive Technology Market Overview
  • 29.2. Africa Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Assisted Reproductive Technology Market Competitive Landscape And Company Profiles

  • 30.1. Assisted Reproductive Technology Market Competitive Landscape
  • 30.2. Assisted Reproductive Technology Market Company Profiles
    • 30.2.1. Cooper Surgical Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Ferring Pharmaceuticals Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Hamilton Thorne Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Genea Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Assisted Reproductive Technology Market Competitive Benchmarking

32. Global Assisted Reproductive Technology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Assisted Reproductive Technology Market

34. Assisted Reproductive Technology Market Future Outlook and Potential Analysis

  • 34.1 Assisted Reproductive Technology Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Assisted Reproductive Technology Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Assisted Reproductive Technology Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer